BTIG


BTIG Reiterates Buy on Herbalife Ltd. Following 35th Anniversary Event

In a research report published today, March 9th, BTIG analyst April Scee reiterated a Buy rating on Herbalife Ltd. (NYSE:HLF) with a price target …

Why BTIG Thinks Cheniere Energy Weakness is Fleeting Technical

BTIG analyst William Frohnhoefer came out with his views on Cheniere Energy Inc. (NYSE MKT:LNG), after the company announced Tuesday that it would place a new …

BTIG Reiterates Neutral Rating On Keryx Biopharmaceuticals Following Q4 Earnings Release

BTIG’s healthcare analyst Hartaj Singh came out with a research note on Keryx Biopharmaceuticals (NASDAQ:KERX), after the company reported its fourth-quarter financial results and provided a corporate update. The analyst …

BTIG Reiterates Buy Rating On MBIA Following 4Q14 Results

BTIG analyst Mark Palmer maintained a Buy rating on MBIA Inc. (NYSE:MBI) with a price target of $12.

BTIG Remains Neutral On Keryx Biopharmaceuticals Following Earnings Update

In a research report issued Friday, BTIG analyst Hartaj Singh reiterated a Neutral rating on Keryx Biopharmaceuticals (NASDAQ:KERX), after the company released its full …

BTIG Maintains Buy Rating On Cheniere Energy, Sees 31% Upside For The Stock

In a research report issued today, BTIG analyst William Frohnhoefer maintained a Buy rating on Cheniere Energy, Inc. (NYSEMKT:LNG) with a price target of $100, …

BTIG Remains Positive On Genworth Financial Despite Larger-Than-Expected 4Q14 Loss

BTIG analyst Mark Palmer maintained a Buy rating on Genworth Financial Inc (NYSE:GNW) with a $15 price target, which represents a potential upside of …

Illumina: Solid Margin Upside Affirms Bullish Outlook For 2015, Says BTIG’s Dane Leone

BTIG analyst Dane Leone reiterated a Buy rating on Illumina (NASDAQ:ILMN) and raised the price target to $240 (from $220), as the company reported fourth-quarter results and updated 2015 …

BTIG’s April Scee Comments On Avon In Light Of TPG Acquisition Rumors

BTIG analyst April Scee weighed in with a few comments on Avon Products (NYSE:AVP), following rumors that private equity TPG Capital is in talks to acquire the company. …

BTIG Maintains Bullish View On Pharmacyclics On The Back Of Strong Imbruvica 2015 Guidance

In a research report published Tuesday, BTIG analyst Hartaj Singh maintained a Buy rating on Pharmacyclics (NASDAQ :PCYC) with a $225 price target, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts